Q1 2023 Holdings
Filed 2023-05-15 | 72 holdings | $252.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Orchard Therapeutics PLC | SPON ADS NEW | 68570P200 | $138 | 25,664 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $364 | 319,057 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $402 | 540,600 | 0.0% |
| Chemomab Therapeutics LTD | SPONSORED ADS | 16385C104 | $458 | 288,169 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $489 | 199,547 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $504 | 1,481,511 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $662 | 225,065 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $1.1K | 272,537 | 0.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $1.1K | 81,963 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $1.4K | 1,628,980 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $1.7K | 900,649 | 0.0% |
| Galecto Inc(GLTOUSD) | COM | 36322Q107 | $2.0K | 1,020,238 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.2K | 561,600 | 0.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $2.9K | 1,217,882 | 0.0% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $3.1K | 1,000,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.1K | 1,081,490 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $3.2K | 1,181,115 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $3.7K | 1,952,032 | 0.0% |
| Icosavax Inc | COM | 45114M109 | $3.7K | 643,825 | 0.0% |
| Greenlight Biosciencs Hlds P | COMMON STOCK | 39536G105 | $4.0K | 9,188,659 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $4.7K | 593,043 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $4.8K | 350,000 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $5.0K | 350,000 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $6.0K | 616,786 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $6.6K | 816,460 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $8.3K | 4,250,000 | 0.0% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $9.0K | 734,350 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $9.1K | 1,087,807 | 0.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $9.4K | 2,353,141 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $10.3K | 275,000 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $10.7K | 3,082,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $11.1K | 1,271,429 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $11.9K | 650,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $12.2K | 325,000 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $13.3K | 1,000,000 | 0.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $13.7K | 576,373 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $14.5K | 80,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $14.9K | 868,550 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $15.2K | 110,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $16.3K | 4,116,949 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $17.5K | 1,050,000 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $17.6K | 322,240 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $17.9K | 1,421,422 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $19.7K | 2,946,887 | 0.0% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $21.6K | 2,536,617 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $21.6K | 850,000 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $22.5K | 2,893,717 | 0.0% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $23.2K | 2,386,181 | 0.0% |
| Rain Oncology Inc | COM | 75082Q105 | $26.0K | 2,978,660 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $29.7K | 5,150,000 | 0.0% |